| | |
| Clinical data | |
|---|---|
| Other names | PR 741-976; a,a-Dimethyl-1-adamantaneethylamine; [2-(1-Adamantyl)-1,1-dimethylethyl]amine |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C14H25N |
| Molar mass | 207.361 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Somantadine (INN ; developmental code name PR 741-976), or somantadine hydrochloride (USAN ) in the case of the hydrochloride salt, is an experimental antiviral drug of the adamantane family related to amantadine and rimantadine that was never marketed. [1] [2] [3] It was first described by 1978. [1]